S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
pixel
pixel
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
pixel
pixel
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
pixel
pixel
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
pixel
pixel
Log in
NYSE:CVS

CVS Health Stock Forecast, Price & News

$75.25
-0.15 (-0.20 %)
(As of 01/20/2021 12:00 AM ET)
Add
Compare
Today's Range
$74.59
Now: $75.25
$75.46
50-Day Range
$67.22
MA: $71.68
$76.26
52-Week Range
$52.04
Now: $75.25
$77.23
Volume4.71 million shs
Average Volume7.60 million shs
Market Capitalization$98.50 billion
P/E Ratio12.44
Dividend Yield2.65%
Beta0.82
CVS Health Corporation provides health services and plans in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans (PDPs), Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail order, mail order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. Its Retail/LTC segment sells prescription and over-the-counter drugs, beauty and personal care products, and cosmetics; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. As of December 31, 2019, it operated approximately 9,900 retail locations and 1,100 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. The company was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
CVS Health logo

MarketRank

Overall MarketRank

2.54 out of 5 stars

Retail/Wholesale Sector

6th out of 383 stocks

Drug Stores & Proprietary Stores Industry

1st out of 14 stocks

Analyst Opinion: 3.4Community Rank: 3.2Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
CUSIP12665010
Phone401-765-1500
Employees290,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$256.78 billion
Cash Flow$10.32 per share
Book Value$49.33 per share

Profitability

Net Income$6.63 billion

Miscellaneous

Outstanding Shares1,308,914,000
Market Cap$98.50 billion
Next Earnings Date2/10/2021 (Estimated)
OptionableOptionable
$75.25
-0.15 (-0.20 %)
(As of 01/20/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CVS Health (NYSE:CVS) Frequently Asked Questions

How has CVS Health's stock been impacted by Coronavirus (COVID-19)?

CVS Health's stock was trading at $61.31 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CVS stock has increased by 22.7% and is now trading at $75.25.
View which stocks have been most impacted by COVID-19
.

Is CVS Health a buy right now?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last twelve months. There are currently 3 hold ratings, 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CVS Health stock.
View analyst ratings for CVS Health
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than CVS Health?

Wall Street analysts have given CVS Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CVS Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Thomas Greco's approval rating as CVS Health's CEO?

538 employees have rated CVS Health CEO Thomas Greco on Glassdoor.com. Thomas Greco has an approval rating of 63% among CVS Health's employees. This puts Thomas Greco in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is CVS Health's next earnings date?

CVS Health is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th 2021.
View our earnings forecast for CVS Health
.

How were CVS Health's earnings last quarter?

CVS Health Co. (NYSE:CVS) announced its quarterly earnings results on Wednesday, November, 11th. The pharmacy operator reported $1.66 EPS for the quarter, beating the consensus estimate of $1.33 by $0.33. The pharmacy operator earned $67.05 billion during the quarter, compared to the consensus estimate of $66.54 billion. CVS Health had a return on equity of 15.60% and a net margin of 2.99%. The business's revenue was up 3.5% on a year-over-year basis. During the same period last year, the company posted $1.84 earnings per share.
View CVS Health's earnings history
.

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health announced a quarterly dividend on Monday, January 4th. Investors of record on Friday, January 22nd will be given a dividend of $0.50 per share on Monday, February 1st. This represents a $2.00 annualized dividend and a dividend yield of 2.66%. The ex-dividend date of this dividend is Thursday, January 21st.
View CVS Health's dividend history
.

Is CVS Health a good dividend stock?

CVS Health pays an annual dividend of $2.00 per share and currently has a dividend yield of 2.65%. CVS Health does not yet have a strock track record of dividend growth. The dividend payout ratio of CVS Health is 28.25%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CVS Health will have a dividend payout ratio of 26.56% next year. This indicates that CVS Health will be able to sustain or increase its dividend.
View CVS Health's dividend history.

What guidance has CVS Health issued on next quarter's earnings?

CVS Health updated its FY20 earnings guidance on Friday, November, 6th. The company provided EPS guidance of $7.35-7.42 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.23.

What price target have analysts set for CVS?

16 analysts have issued twelve-month price targets for CVS Health's stock. Their forecasts range from $66.00 to $101.00. On average, they expect CVS Health's share price to reach $82.93 in the next twelve months. This suggests a possible upside of 10.2% from the stock's current price.
View analysts' price targets for CVS Health
or view Wall Street analyst' top-rated stocks.

Who are some of CVS Health's key competitors?

What other stocks do shareholders of CVS Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), The Walt Disney (DIS), Johnson & Johnson (JNJ), NVIDIA (NVDA), Cisco Systems (CSCO), AbbVie (ABBV), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA) and The Home Depot (HD).

Who are CVS Health's key executives?

CVS Health's management team includes the following people:
  • Mr. Larry J. Merlo, Pres, CEO & Director (Age 64, Pay $12.83M)
  • Ms. Eva C. Boratto, Exec. VP & CFO (Age 53, Pay $4.56M)
  • Mr. Jonathan C. Roberts, Exec. VP & COO (Age 64, Pay $7.55M)
  • Mr. Thomas Michael Moriarty, Exec. VP, Chief Policy & External Affairs Officer and Gen. Counsel (Age 56, Pay $5.78M)
  • Mr. James David Clark, Sr. VP, Controller & Chief Accounting Officer (Age 55)
  • Ms. Valerie C. Haertel, Sr. VP of Investor Relations
  • Mr. David A. Falkowski, Exec. VP & Chief Compliance Officer
  • Ms. Lisa G. Bisaccia, Exec. VP & Chief HR Officer (Age 64)
  • Mr. Troyen A. Brennan M.D., M.P.H., J.D., Exec. VP & Chief Medical Officer (Age 65)
  • Mr. Joshua Matthew Flum, Exec. VP of Enterprise Strategy & Digital (Age 50)

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

Who are CVS Health's major shareholders?

CVS Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include Scharf Investments LLC (0.15%), RNC Capital Management LLC (0.05%), Gateway Investment Advisers LLC (0.04%), Douglas Lane & Associates LLC (0.04%), Gillespie Robinson & Grimm Inc. (0.03%) and Rhenman & Partners Asset Management AB (0.03%). Company insiders that own CVS Health stock include Alan Lotvin, C David Brown II, David W Dorman, Edward J Ludwig, Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Larry J Merlo, Lisa Bisaccia, Troyen A Brennan and Vost Collin.
View institutional ownership trends for CVS Health
.

Which institutional investors are selling CVS Health stock?

CVS stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Gateway Investment Advisers LLC, RNC Capital Management LLC, Cohen Klingenstein LLC, Pacer Advisors Inc., Pacifica Partners Inc., Legacy Private Trust Co., and Meridian Wealth Management LLC. Company insiders that have sold CVS Health company stock in the last year include Alan Lotvin, James David Clark, and Lisa Bisaccia.
View insider buying and selling activity for CVS Health
or view top insider-selling stocks.

Which institutional investors are buying CVS Health stock?

CVS stock was purchased by a variety of institutional investors in the last quarter, including Scharf Investments LLC, Rhenman & Partners Asset Management AB, Kestra Advisory Services LLC, Signature Wealth Management Group, Douglas Lane & Associates LLC, Monument Capital Management, Vision Capital Management Inc., and IFM Investors Pty Ltd. Company insiders that have bought CVS Health stock in the last two years include Alan Lotvin, C David Brown II, David W Dorman, and Edward J Ludwig.
View insider buying and selling activity for CVS Health
or or view top insider-buying stocks.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $75.25.

How big of a company is CVS Health?

CVS Health has a market capitalization of $98.50 billion and generates $256.78 billion in revenue each year. The pharmacy operator earns $6.63 billion in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 290,000 workers across the globe.

What is CVS Health's official website?

The official website for CVS Health is www.cvshealth.com.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]

This page was last updated on 1/21/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.